T. Ikegami et al., Experimental study of the effects of deletion variant of hepatocyte growthfactor on hepatic ischaemia-reperfusion injury, BR J SURG, 87(1), 2000, pp. 59-64
Background: Hepatic ischaemia-reperfusion (IR) injury is still a serious co
mplication following liver surgery. The effect of the deletion variant of h
epatocyte growth factor (dHGF) on hepatic IR injury was examined in rats.
Methods: Male Wistar rats were divided into two groups after 90 min of part
ial liver ischaemia: the dHGF group which was given dHGF 0.5 mg/kg intraven
ously immediately after reperfusion, followed by 0.5 mg/kg every 12 h, and
the control group, which received vehicle buffer only. Serum chemistry, his
topathological findings and liver weights were compared between the groups.
Results: In the dHGF group, the increase in serum alanine transaminase and
hyaluronic acid levels was significantly reduced, and the serum albumin lev
el increased after reperfusion. The extent of hepatic necrosis 24 h after r
eperfusion was decreased in the dHGF group. Moreover, the proportion of ter
minal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate
nick end labelling-positive hepatocytes 6 h after reperfusion was reduced
in the dHGF group. The non-ischaemic-, ischaemic- and whole-liver weight :
body-weight ratio significantly increased in the dHGF group after reperfusi
on. The proportion of proliferating cell nuclear antigen-positive hepatocyt
es in the dHGF group markedly increased after 6 h after reperfusion in the
non-ischaemic lobes, while in the ischaemic lobes it increased 24 h after r
eperfusion.
Conclusion: These data suggest that dHGF not only improves recovery from IR
injury, but also accelerates recovery from these injuries. dHGF may be an
effective pharmacological agent for prevention and treatment of hepatic IR
injury.